

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 9.31794550 |
| 2 | digestion (GO:0007586) | 8.27231875 |
| 3 | protein retention in ER lumen (GO:0006621) | 8.10100699 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.54697985 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 6.09277667 |
| 6 | valine metabolic process (GO:0006573) | 5.77646331 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 5.68428911 |
| 8 | cobalamin metabolic process (GO:0009235) | 5.30130183 |
| 9 | cholesterol catabolic process (GO:0006707) | 4.84848020 |
| 10 | sterol catabolic process (GO:0016127) | 4.84848020 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 4.83833523 |
| 12 | response to peptidoglycan (GO:0032494) | 4.82950608 |
| 13 | galactose catabolic process (GO:0019388) | 4.75621263 |
| 14 | transcytosis (GO:0045056) | 4.63700289 |
| 15 | definitive hemopoiesis (GO:0060216) | 4.62638024 |
| 16 | cellular extravasation (GO:0045123) | 4.62110878 |
| 17 | peptidyl-proline hydroxylation (GO:0019511) | 4.60853981 |
| 18 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.58241263 |
| 19 | regulation of mast cell degranulation (GO:0043304) | 4.55995862 |
| 20 | protein targeting to ER (GO:0045047) | 4.47459530 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 4.46436758 |
| 22 | viral transcription (GO:0019083) | 4.42706487 |
| 23 | leukotriene biosynthetic process (GO:0019370) | 4.42587766 |
| 24 | mitochondrial calcium ion transport (GO:0006851) | 4.37582161 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.33690928 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.33690928 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 4.33690928 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 4.33690928 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 4.33690928 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.33690928 |
| 31 | translational termination (GO:0006415) | 4.31072902 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30022519 |
| 33 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.29943071 |
| 34 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.26370929 |
| 35 | protein localization to endoplasmic reticulum (GO:0070972) | 4.24925147 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 4.24769447 |
| 37 | neutrophil activation (GO:0042119) | 4.24181111 |
| 38 | detection of other organism (GO:0098543) | 4.19019222 |
| 39 | proline biosynthetic process (GO:0006561) | 4.17261007 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 4.16339477 |
| 41 | detection of bacterium (GO:0016045) | 4.14564342 |
| 42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.09626263 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.06607913 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98922916 |
| 45 | negative regulation of cell killing (GO:0031342) | 3.98922916 |
| 46 | positive regulation of mast cell degranulation (GO:0043306) | 3.97320229 |
| 47 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.97320229 |
| 48 | regulation of mast cell activation (GO:0033003) | 3.92593884 |
| 49 | branched-chain amino acid catabolic process (GO:0009083) | 3.92178536 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 3.90480459 |
| 51 | microglial cell activation (GO:0001774) | 3.89344029 |
| 52 | COPI coating of Golgi vesicle (GO:0048205) | 3.87622675 |
| 53 | Golgi transport vesicle coating (GO:0048200) | 3.87622675 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.87145384 |
| 55 | thrombin receptor signaling pathway (GO:0070493) | 3.86048319 |
| 56 | translational elongation (GO:0006414) | 3.85613640 |
| 57 | positive regulation of heat generation (GO:0031652) | 3.85432567 |
| 58 | branched-chain amino acid metabolic process (GO:0009081) | 3.84593972 |
| 59 | glycolipid catabolic process (GO:0019377) | 3.82819609 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80273587 |
| 61 | regulation of B cell differentiation (GO:0045577) | 3.79123996 |
| 62 | granulocyte activation (GO:0036230) | 3.78247871 |
| 63 | regulation of fever generation (GO:0031620) | 3.74965468 |
| 64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.71781768 |
| 65 | neutrophil mediated immunity (GO:0002446) | 3.68554564 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 3.68100929 |
| 67 | positive regulation of granulocyte differentiation (GO:0030854) | 3.66757445 |
| 68 | megakaryocyte development (GO:0035855) | 3.66576601 |
| 69 | response to muramyl dipeptide (GO:0032495) | 3.66446985 |
| 70 | membrane lipid catabolic process (GO:0046466) | 3.63335454 |
| 71 | signal peptide processing (GO:0006465) | 3.60315193 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57166281 |
| 73 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57166281 |
| 74 | regulation of phospholipase A2 activity (GO:0032429) | 3.55553617 |
| 75 | protein hydroxylation (GO:0018126) | 3.54104185 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 3.53970123 |
| 77 | intestinal absorption (GO:0050892) | 3.53944949 |
| 78 | B cell mediated immunity (GO:0019724) | 3.53743898 |
| 79 | leukocyte aggregation (GO:0070486) | 3.47126129 |
| 80 | protein maturation by protein folding (GO:0022417) | 3.46156484 |
| 81 | leukocyte degranulation (GO:0043299) | 3.44085519 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43104098 |
| 83 | response to host immune response (GO:0052572) | 3.43104098 |
| 84 | cysteine metabolic process (GO:0006534) | 3.42993884 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 3.40645722 |
| 86 | defense response to protozoan (GO:0042832) | 3.39986703 |
| 87 | regulation of platelet aggregation (GO:0090330) | 3.35512070 |
| 88 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34509550 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.31841025 |
| 90 | negative regulation of interleukin-12 production (GO:0032695) | 3.30489800 |
| 91 | GDP-mannose metabolic process (GO:0019673) | 3.30477551 |
| 92 | ribosomal small subunit biogenesis (GO:0042274) | 3.29644144 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26344349 |
| 94 | detection of external biotic stimulus (GO:0098581) | 3.25902536 |
| 95 | response to protozoan (GO:0001562) | 3.25902210 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.25444070 |
| 97 | positive regulation of nuclease activity (GO:0032075) | 3.23967802 |
| 98 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.23058300 |
| 99 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.22882226 |
| 100 | regulation of regulated secretory pathway (GO:1903305) | 3.22799706 |
| 101 | viral life cycle (GO:0019058) | 3.22473113 |
| 102 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.21093316 |
| 103 | translational initiation (GO:0006413) | 3.18336469 |
| 104 | DNA deamination (GO:0045006) | 3.16809608 |
| 105 | hypotonic response (GO:0006971) | 3.14523807 |
| 106 | leukotriene metabolic process (GO:0006691) | 3.14036976 |
| 107 | response to interferon-beta (GO:0035456) | 3.13953432 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 3.13534990 |
| 109 | toxin transport (GO:1901998) | 3.13006840 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12539286 |
| 111 | serine family amino acid biosynthetic process (GO:0009070) | 3.12392631 |
| 112 | cellular protein complex disassembly (GO:0043624) | 3.10942589 |
| 113 | pentose-phosphate shunt (GO:0006098) | 3.10664623 |
| 114 | macrophage activation (GO:0042116) | 3.10624777 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10574321 |
| 116 | regulation of erythrocyte differentiation (GO:0045646) | 3.10225870 |
| 117 | respiratory burst (GO:0045730) | 3.08358675 |
| 118 | response to host (GO:0075136) | 3.08090163 |
| 119 | response to host defenses (GO:0052200) | 3.08090163 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08090163 |
| 121 | germinal center formation (GO:0002467) | 3.08059707 |
| 122 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07785996 |
| 123 | ceramide catabolic process (GO:0046514) | 3.06891401 |
| 124 | formation of translation preinitiation complex (GO:0001731) | 3.05166520 |
| 125 | negative regulation of digestive system process (GO:0060457) | 3.04541468 |
| 126 | protein targeting to membrane (GO:0006612) | 3.02189804 |
| 127 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.01616653 |
| 128 | regulation of nuclease activity (GO:0032069) | 2.93775139 |
| 129 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93214689 |
| 130 | detection of biotic stimulus (GO:0009595) | 2.93160093 |
| 131 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92563725 |
| 132 | response to endoplasmic reticulum stress (GO:0034976) | 2.89383074 |
| 133 | cellular response to unfolded protein (GO:0034620) | 2.88883787 |
| 134 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88399630 |
| 135 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88399630 |
| 136 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.88265196 |
| 137 | regulation of antigen processing and presentation (GO:0002577) | 2.87855672 |
| 138 | L-serine metabolic process (GO:0006563) | 2.85328081 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85268521 |
| 140 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84961121 |
| 141 | regulation of granulocyte differentiation (GO:0030852) | 2.84420023 |
| 142 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84004076 |
| 143 | myeloid leukocyte mediated immunity (GO:0002444) | 2.83927754 |
| 144 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83763210 |
| 145 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82995134 |
| 146 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82010765 |
| 147 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81861339 |
| 148 | positive thymic T cell selection (GO:0045059) | 2.81096961 |
| 149 | mast cell activation (GO:0045576) | 2.80305387 |
| 150 | regulation of heat generation (GO:0031650) | 2.80049768 |
| 151 | cellular response to topologically incorrect protein (GO:0035967) | 2.78843857 |
| 152 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.78799351 |
| 153 | regulation of B cell apoptotic process (GO:0002902) | 2.77753337 |
| 154 | protein complex disassembly (GO:0043241) | 2.77424266 |
| 155 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76944211 |
| 156 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.76772585 |
| 157 | positive regulation of regulated secretory pathway (GO:1903307) | 2.76376652 |
| 158 | one-carbon compound transport (GO:0019755) | 2.75818543 |
| 159 | maintenance of protein localization in organelle (GO:0072595) | 2.74821846 |
| 160 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74006333 |
| 161 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.73718895 |
| 162 | negative thymic T cell selection (GO:0045060) | 2.72700372 |
| 163 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.72234499 |
| 164 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.72067575 |
| 165 | regulation of platelet activation (GO:0010543) | 2.71948032 |
| 166 | glutamine metabolic process (GO:0006541) | 2.69428764 |
| 167 | ER-nucleus signaling pathway (GO:0006984) | 2.68984614 |
| 168 | Peyers patch development (GO:0048541) | 2.68551853 |
| 169 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.68551853 |
| 170 | peptidyl-asparagine modification (GO:0018196) | 2.68430754 |
| 171 | negative regulation of interleukin-6 production (GO:0032715) | 2.68387109 |
| 172 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.67890903 |
| 173 | NADPH regeneration (GO:0006740) | 2.67699929 |
| 174 | fucose catabolic process (GO:0019317) | 2.67533314 |
| 175 | L-fucose metabolic process (GO:0042354) | 2.67533314 |
| 176 | L-fucose catabolic process (GO:0042355) | 2.67533314 |
| 177 | cellular modified amino acid catabolic process (GO:0042219) | 2.67170102 |
| 178 | proline metabolic process (GO:0006560) | 2.66912270 |
| 179 | peptide catabolic process (GO:0043171) | 2.65883915 |
| 180 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.64715885 |
| 181 | endosome to melanosome transport (GO:0035646) | 2.63622243 |
| 182 | endosome to pigment granule transport (GO:0043485) | 2.63622243 |
| 183 | hexose catabolic process (GO:0019320) | 2.62876026 |
| 184 | creatine metabolic process (GO:0006600) | 2.60722986 |
| 185 | platelet aggregation (GO:0070527) | 2.59056725 |
| 186 | retinoic acid receptor signaling pathway (GO:0048384) | 2.58922805 |
| 187 | translation (GO:0006412) | 2.57011086 |
| 188 | exocrine pancreas development (GO:0031017) | 11.6519693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.79575335 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.57047529 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.47435251 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15217266 |
| 5 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89664040 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78475391 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.58723027 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.51105997 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.51101137 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44855186 |
| 11 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42839049 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.37850439 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25269563 |
| 14 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15106359 |
| 15 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.14766610 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14244798 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12764853 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11012145 |
| 19 | GATA1_19941826_ChIP-Seq_K562_Human | 2.09471090 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08333987 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01130839 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97779272 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.96901237 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96848968 |
| 25 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.96028483 |
| 26 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.95527186 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95358749 |
| 28 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89185682 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85790745 |
| 30 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.83987475 |
| 31 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.81808184 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81234970 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80693403 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77540418 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73802665 |
| 36 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73575667 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72249475 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71506117 |
| 39 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69499332 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67484991 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65538221 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63195967 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.63157414 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60229717 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59923168 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59351080 |
| 47 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55240791 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54339190 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52576203 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.51770223 |
| 51 | GATA2_19941826_ChIP-Seq_K562_Human | 1.49444101 |
| 52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49186887 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.47040026 |
| 54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.46435741 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45537062 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44542360 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43688801 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42947156 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42203221 |
| 60 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.41368649 |
| 61 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40507076 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39174587 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37265529 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37215180 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35569395 |
| 66 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.34816863 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34654093 |
| 68 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33625013 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.33193654 |
| 70 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.32265171 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31990704 |
| 72 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.30883895 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28517154 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28312972 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28182450 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28047091 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.27261008 |
| 78 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26767173 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26337163 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26043725 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24603912 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24590405 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23864739 |
| 84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.19378742 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19050808 |
| 86 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18466400 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18275919 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18094543 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17956107 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17673006 |
| 91 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.16900349 |
| 92 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16500208 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15950601 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.15427046 |
| 95 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14945795 |
| 96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14035749 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13866242 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12781745 |
| 99 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12284248 |
| 100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12205960 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12187178 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11966211 |
| 103 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11887691 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11800241 |
| 105 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11572720 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11263019 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10811854 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10095386 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09894565 |
| 110 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08829368 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08764166 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08642746 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08161917 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07928969 |
| 115 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06893971 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05167857 |
| 117 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04035892 |
| 118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03456828 |
| 119 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02196044 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01918547 |
| 121 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00319445 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99479395 |
| 123 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.99408602 |
| 124 | * P300_27268052_Chip-Seq_Bcells_Human | 0.98538661 |
| 125 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98418870 |
| 126 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98045506 |
| 127 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97997529 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.97719356 |
| 129 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.97686760 |
| 130 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96554136 |
| 131 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96341707 |
| 132 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95683506 |
| 133 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95370912 |
| 134 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.93489846 |
| 135 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92952375 |
| 136 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92767640 |
| 137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92264418 |
| 138 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91368444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 6.29797915 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.98091324 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 4.88739133 |
| 4 | MP0005365_abnormal_bile_salt | 4.12258428 |
| 5 | MP0003868_abnormal_feces_composition | 3.14474752 |
| 6 | MP0010386_abnormal_urinary_bladder | 3.07499262 |
| 7 | MP0005084_abnormal_gallbladder_morpholo | 3.05342170 |
| 8 | MP0006054_spinal_hemorrhage | 2.83645272 |
| 9 | MP0001664_abnormal_digestion | 2.83567845 |
| 10 | MP0004147_increased_porphyrin_level | 2.80865904 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.49824110 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 2.22467371 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.19206200 |
| 14 | MP0005367_renal/urinary_system_phenotyp | 2.11191724 |
| 15 | MP0000516_abnormal_urinary_system | 2.11191724 |
| 16 | MP0000490_abnormal_crypts_of | 2.08119934 |
| 17 | MP0002132_abnormal_respiratory_system | 1.98664465 |
| 18 | MP0001873_stomach_inflammation | 1.94950007 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.92238077 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.90863958 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.86894848 |
| 22 | MP0003300_gastrointestinal_ulcer | 1.76620713 |
| 23 | MP0003959_abnormal_lean_body | 1.76582987 |
| 24 | MP0006082_CNS_inflammation | 1.64966562 |
| 25 | MP0003638_abnormal_response/metabolism_ | 1.63237069 |
| 26 | MP0009278_abnormal_bone_marrow | 1.62833496 |
| 27 | MP0003828_pulmonary_edema | 1.61635300 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.57955198 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.56369455 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.56124255 |
| 31 | MP0003436_decreased_susceptibility_to | 1.50372772 |
| 32 | MP0004947_skin_inflammation | 1.50085532 |
| 33 | MP0008004_abnormal_stomach_pH | 1.49059917 |
| 34 | MP0009764_decreased_sensitivity_to | 1.48214348 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.45681992 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.45681992 |
| 37 | MP0000685_abnormal_immune_system | 1.45260666 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.42357065 |
| 39 | MP0001851_eye_inflammation | 1.35890654 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.31452531 |
| 41 | MP0001663_abnormal_digestive_system | 1.30137206 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.28995776 |
| 43 | MP0008260_abnormal_autophagy | 1.28294112 |
| 44 | MP0001756_abnormal_urination | 1.28092658 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.25876621 |
| 46 | MP0009785_altered_susceptibility_to | 1.25783138 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.23996924 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.20969003 |
| 49 | MP0003075_altered_response_to | 1.20121882 |
| 50 | MP0003303_peritoneal_inflammation | 1.18962810 |
| 51 | MP0005451_abnormal_body_composition | 1.17402978 |
| 52 | MP0002398_abnormal_bone_marrow | 1.16625354 |
| 53 | MP0005671_abnormal_response_to | 1.15453695 |
| 54 | MP0003866_abnormal_defecation | 1.15387807 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.15156043 |
| 56 | MP0005025_abnormal_response_to | 1.14311548 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.12914575 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.10732390 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.08347698 |
| 60 | MP0005381_digestive/alimentary_phenotyp | 1.08151118 |
| 61 | MP0002419_abnormal_innate_immunity | 1.06575983 |
| 62 | MP0001944_abnormal_pancreas_morphology | 1.04392877 |
| 63 | MP0001819_abnormal_immune_cell | 1.02688081 |
| 64 | MP0001764_abnormal_homeostasis | 1.02422537 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.02026110 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.01583508 |
| 67 | MP0002722_abnormal_immune_system | 1.01552218 |
| 68 | MP0005165_increased_susceptibility_to | 1.00501369 |
| 69 | MP0001800_abnormal_humoral_immune | 0.98841306 |
| 70 | MP0002405_respiratory_system_inflammati | 0.98000705 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.97804709 |
| 72 | MP0000470_abnormal_stomach_morphology | 0.94435523 |
| 73 | MP0008469_abnormal_protein_level | 0.94405332 |
| 74 | MP0002723_abnormal_immune_serum | 0.94175790 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.93403401 |
| 76 | MP0002452_abnormal_antigen_presenting | 0.92949411 |
| 77 | MP0005448_abnormal_energy_balance | 0.92286579 |
| 78 | MP0002429_abnormal_blood_cell | 0.90843891 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.89541636 |
| 80 | MP0000716_abnormal_immune_system | 0.88587480 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.87805133 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.87243019 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.86977996 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.86169582 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.85374774 |
| 86 | MP0008438_abnormal_cutaneous_collagen | 0.84718774 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 0.84514345 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.83131601 |
| 89 | MP0005166_decreased_susceptibility_to | 0.83029654 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.82446909 |
| 91 | MP0002148_abnormal_hypersensitivity_rea | 0.82223138 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.82126574 |
| 93 | MP0004883_abnormal_blood_vessel | 0.81999956 |
| 94 | MP0003186_abnormal_redox_activity | 0.81681918 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.81677583 |
| 96 | MP0005332_abnormal_amino_acid | 0.81534618 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.80032123 |
| 98 | MP0005390_skeleton_phenotype | 0.79658031 |
| 99 | MP0005310_abnormal_salivary_gland | 0.79497564 |
| 100 | MP0000249_abnormal_blood_vessel | 0.78029419 |
| 101 | MP0003693_abnormal_embryo_hatching | 0.77586911 |
| 102 | MP0004510_myositis | 0.77134756 |
| 103 | MP0000598_abnormal_liver_morphology | 0.76683098 |
| 104 | MP0000858_altered_metastatic_potential | 0.75748588 |
| 105 | MP0005164_abnormal_response_to | 0.75511148 |
| 106 | MP0000343_altered_response_to | 0.73965294 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.73374203 |
| 108 | MP0000534_abnormal_ureter_morphology | 0.72473137 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.71620347 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.71287890 |
| 111 | MP0002009_preneoplasia | 0.70547493 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.70078206 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.69044426 |
| 114 | MP0003279_aneurysm | 0.68811687 |
| 115 | MP0002006_tumorigenesis | 0.68645657 |
| 116 | MP0002135_abnormal_kidney_morphology | 0.68593227 |
| 117 | MP0005535_abnormal_body_temperature | 0.68403119 |
| 118 | MP0008874_decreased_physiological_sensi | 0.64173961 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.64077049 |
| 120 | MP0009763_increased_sensitivity_to | 0.64019145 |
| 121 | MP0001853_heart_inflammation | 0.63992494 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.62414189 |
| 123 | MP0001790_abnormal_immune_system | 0.61854940 |
| 124 | MP0005387_immune_system_phenotype | 0.61854940 |
| 125 | MP0002277_abnormal_respiratory_mucosa | 0.61782489 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.61494235 |
| 127 | MP0003795_abnormal_bone_structure | 0.61367880 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.59647710 |
| 129 | MP0002138_abnormal_hepatobiliary_system | 0.58008251 |
| 130 | MP0003724_increased_susceptibility_to | 0.57901454 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.55383651 |
| 132 | MP0004381_abnormal_hair_follicle | 0.53529755 |
| 133 | MP0003448_altered_tumor_morphology | 0.52630120 |
| 134 | MP0008873_increased_physiological_sensi | 0.50763926 |
| 135 | MP0000681_abnormal_thyroid_gland | 0.50732546 |
| 136 | MP0005410_abnormal_fertilization | 0.48863179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 7.50458796 |
| 2 | Aortic aneurysm (HP:0004942) | 6.49208252 |
| 3 | Facial diplegia (HP:0001349) | 4.79324059 |
| 4 | Aortic dissection (HP:0002647) | 4.77604073 |
| 5 | Increased density of long bones (HP:0006392) | 4.73855591 |
| 6 | Stomatitis (HP:0010280) | 4.66847454 |
| 7 | Thrombocytosis (HP:0001894) | 4.45073981 |
| 8 | Steatorrhea (HP:0002570) | 4.39814115 |
| 9 | Obstructive lung disease (HP:0006536) | 4.36906358 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.36906358 |
| 11 | Short chin (HP:0000331) | 4.29172467 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.26688114 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.99839907 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.89648465 |
| 15 | Hypoproteinemia (HP:0003075) | 3.84064975 |
| 16 | Meningitis (HP:0001287) | 3.69803071 |
| 17 | Petechiae (HP:0000967) | 3.64991487 |
| 18 | Encephalitis (HP:0002383) | 3.54822893 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52908362 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52908362 |
| 21 | Fatigue (HP:0012378) | 3.47816101 |
| 22 | Orchitis (HP:0100796) | 3.44317155 |
| 23 | Recurrent skin infections (HP:0001581) | 3.37352648 |
| 24 | Abnormality of subcutaneous fat tissue (HP:0001001) | 3.37054561 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.34027587 |
| 26 | Joint stiffness (HP:0001387) | 3.25477687 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22276882 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.22204854 |
| 29 | Fat malabsorption (HP:0002630) | 3.20238897 |
| 30 | Aortic regurgitation (HP:0001659) | 3.17703130 |
| 31 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.16149837 |
| 32 | Optic neuritis (HP:0100653) | 3.14613570 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.14613570 |
| 34 | Increased IgE level (HP:0003212) | 3.13516156 |
| 35 | Granulocytopenia (HP:0001913) | 3.09643147 |
| 36 | Cellulitis (HP:0100658) | 3.07569912 |
| 37 | IgM deficiency (HP:0002850) | 3.07333078 |
| 38 | Decreased subcutaneous fat (HP:0001002) | 3.02569448 |
| 39 | Gastrointestinal dysmotility (HP:0002579) | 2.95872188 |
| 40 | Hypoplasia of the pons (HP:0012110) | 2.95634741 |
| 41 | Episodic fever (HP:0001954) | 2.95154873 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.94192704 |
| 43 | Abnormal number of erythroid precursors (HP:0012131) | 2.93841041 |
| 44 | Urticaria (HP:0001025) | 2.92266113 |
| 45 | Vasculitis (HP:0002633) | 2.89194287 |
| 46 | Aplastic anemia (HP:0001915) | 2.88765039 |
| 47 | Leukocytosis (HP:0001974) | 2.88073475 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.85151409 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.81571620 |
| 50 | Abnormality of iron homeostasis (HP:0011031) | 2.80995019 |
| 51 | Increased serum ferritin (HP:0003281) | 2.79122090 |
| 52 | Abnormal foot bone ossification (HP:0010675) | 2.76346919 |
| 53 | Long foot (HP:0001833) | 2.75406426 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.72861656 |
| 55 | Epistaxis (HP:0000421) | 2.68297429 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.67117755 |
| 57 | Abnormality of the pons (HP:0007361) | 2.66941971 |
| 58 | Bicuspid aortic valve (HP:0001647) | 2.62719330 |
| 59 | Abnormal platelet volume (HP:0011876) | 2.62321287 |
| 60 | Abnormal protein glycosylation (HP:0012346) | 2.58690593 |
| 61 | Abnormal glycosylation (HP:0012345) | 2.58690593 |
| 62 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.58690593 |
| 63 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.58690593 |
| 64 | Pancreatitis (HP:0001733) | 2.58688611 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.58449875 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.57319415 |
| 67 | Abnormal platelet function (HP:0011869) | 2.56372506 |
| 68 | Impaired platelet aggregation (HP:0003540) | 2.56372506 |
| 69 | Colitis (HP:0002583) | 2.52625126 |
| 70 | Hypochromic microcytic anemia (HP:0004840) | 2.51917412 |
| 71 | Ankle contracture (HP:0006466) | 2.51026979 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.50969342 |
| 73 | Increased IgM level (HP:0003496) | 2.50680165 |
| 74 | Abnormality of the calcaneus (HP:0008364) | 2.48927999 |
| 75 | Abnormality of T cells (HP:0002843) | 2.45784808 |
| 76 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.45386128 |
| 77 | Type I diabetes mellitus (HP:0100651) | 2.44973691 |
| 78 | Increased cerebral lipofuscin (HP:0011813) | 2.44395545 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.44008543 |
| 80 | Acute lymphatic leukemia (HP:0006721) | 2.42483253 |
| 81 | Increased mean platelet volume (HP:0011877) | 2.41922081 |
| 82 | Gingivitis (HP:0000230) | 2.40938034 |
| 83 | Myositis (HP:0100614) | 2.38177822 |
| 84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38090513 |
| 85 | Hemoptysis (HP:0002105) | 2.37076996 |
| 86 | Broad face (HP:0000283) | 2.36833875 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.36505507 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.33499328 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.32476543 |
| 90 | Type I transferrin isoform profile (HP:0003642) | 2.31327434 |
| 91 | Reticulocytopenia (HP:0001896) | 2.29640905 |
| 92 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.28109025 |
| 93 | Premature skin wrinkling (HP:0100678) | 2.26527873 |
| 94 | Aneurysm (HP:0002617) | 2.25864187 |
| 95 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25461116 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24330812 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 2.24330812 |
| 98 | Bruising susceptibility (HP:0000978) | 2.23853575 |
| 99 | Recurrent abscess formation (HP:0002722) | 2.22940246 |
| 100 | Recurrent bacterial skin infections (HP:0005406) | 2.21550119 |
| 101 | Selective tooth agenesis (HP:0001592) | 2.21011548 |
| 102 | Pulmonary embolism (HP:0002204) | 2.20751768 |
| 103 | Exocrine pancreatic insufficiency (HP:0001738) | 2.20745069 |
| 104 | Hypochromic anemia (HP:0001931) | 2.20629593 |
| 105 | Osteomyelitis (HP:0002754) | 2.19939259 |
| 106 | Amaurosis fugax (HP:0100576) | 2.19756754 |
| 107 | Viral hepatitis (HP:0006562) | 2.19601664 |
| 108 | Eosinophilia (HP:0001880) | 2.19474228 |
| 109 | Pustule (HP:0200039) | 2.19029310 |
| 110 | Amyloidosis (HP:0011034) | 2.16967091 |
| 111 | Menorrhagia (HP:0000132) | 2.15828422 |
| 112 | Nonimmune hydrops fetalis (HP:0001790) | 2.15685232 |
| 113 | Vertigo (HP:0002321) | 2.15063921 |
| 114 | Keratoconjunctivitis (HP:0001096) | 2.12821226 |
| 115 | Neoplasm of the heart (HP:0100544) | 2.12279009 |
| 116 | Skin rash (HP:0000988) | 2.11347796 |
| 117 | Hypertensive crisis (HP:0100735) | 2.10763218 |
| 118 | Purpura (HP:0000979) | 2.09049431 |
| 119 | Thoracic kyphosis (HP:0002942) | 2.08698836 |
| 120 | Spontaneous hematomas (HP:0007420) | 2.08644227 |
| 121 | Cerebral aneurysm (HP:0004944) | 2.05250729 |
| 122 | Recurrent viral infections (HP:0004429) | 2.04920779 |
| 123 | Microcytic anemia (HP:0001935) | 2.04199167 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 2.04017189 |
| 125 | Arterial thrombosis (HP:0004420) | 2.03507003 |
| 126 | Sepsis (HP:0100806) | 2.01862269 |
| 127 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.01777382 |
| 128 | Malnutrition (HP:0004395) | 2.01644328 |
| 129 | Poikiloderma (HP:0001029) | 2.01012117 |
| 130 | Polycythemia (HP:0001901) | 2.00785210 |
| 131 | Thrombophlebitis (HP:0004418) | 2.00417651 |
| 132 | Congenital hip dislocation (HP:0001374) | 2.00189208 |
| 133 | Gastrointestinal inflammation (HP:0004386) | 1.99977016 |
| 134 | Skin ulcer (HP:0200042) | 1.97041176 |
| 135 | Beaking of vertebral bodies (HP:0004568) | 1.96900379 |
| 136 | Acute hepatic failure (HP:0006554) | 1.95787107 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94930491 |
| 138 | Spastic diplegia (HP:0001264) | 1.94560987 |
| 139 | Calcaneovalgus deformity (HP:0001848) | 1.90207813 |
| 140 | Abnormality of the thoracic spine (HP:0100711) | 1.89040335 |
| 141 | Maternal diabetes (HP:0009800) | 1.86495648 |
| 142 | Gangrene (HP:0100758) | 1.85374836 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.84664458 |
| 144 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.83603005 |
| 145 | Chest pain (HP:0100749) | 1.83400098 |
| 146 | Progressive muscle weakness (HP:0003323) | 1.83188818 |
| 147 | Chronic otitis media (HP:0000389) | 1.83090154 |
| 148 | Abnormality of the nasal mucosa (HP:0000433) | 1.82262274 |
| 149 | Inflammation of the large intestine (HP:0002037) | 1.81572659 |
| 150 | Anorexia (HP:0002039) | 1.81405493 |
| 151 | Gingival bleeding (HP:0000225) | 1.81320984 |
| 152 | Deformed tarsal bones (HP:0008119) | 1.80347296 |
| 153 | Polygenic inheritance (HP:0010982) | 1.80341817 |
| 154 | Microretrognathia (HP:0000308) | 1.79940091 |
| 155 | Short 4th metacarpal (HP:0010044) | 1.79167029 |
| 156 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.79167029 |
| 157 | T lymphocytopenia (HP:0005403) | 1.79075162 |
| 158 | Dysostosis multiplex (HP:0000943) | 1.78597003 |
| 159 | Abnormality of the pleura (HP:0002103) | 1.78191843 |
| 160 | Abnormality of B cell number (HP:0010975) | 1.78032493 |
| 161 | B lymphocytopenia (HP:0010976) | 1.78032493 |
| 162 | Biconcave vertebral bodies (HP:0004586) | 1.76246082 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.74589471 |
| 164 | Eczematoid dermatitis (HP:0000976) | 1.73704116 |
| 165 | Periodontitis (HP:0000704) | 1.73046665 |
| 166 | Abnormality of the lumbar spine (HP:0100712) | 1.71634314 |
| 167 | Coxa valga (HP:0002673) | 1.71634242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 5.80494900 |
| 2 | BCKDK | 5.26342701 |
| 3 | RIPK4 | 4.83161588 |
| 4 | ERN1 | 4.23274073 |
| 5 | TTN | 3.52090837 |
| 6 | PKN2 | 3.26749631 |
| 7 | EEF2K | 2.65112251 |
| 8 | KIT | 2.56819898 |
| 9 | PIK3CG | 2.55157923 |
| 10 | PAK2 | 2.46732232 |
| 11 | TNK2 | 2.39229150 |
| 12 | TRIB3 | 2.27072798 |
| 13 | ZAP70 | 2.10793263 |
| 14 | EIF2AK3 | 2.04000308 |
| 15 | PRPF4B | 2.03550993 |
| 16 | MAP4K1 | 1.88739459 |
| 17 | NME2 | 1.86997490 |
| 18 | RPS6KB2 | 1.86145698 |
| 19 | MAP2K2 | 1.81559282 |
| 20 | MAPKAPK3 | 1.80215880 |
| 21 | TGFBR1 | 1.76852573 |
| 22 | TIE1 | 1.75910378 |
| 23 | TGFBR2 | 1.71328861 |
| 24 | TESK2 | 1.62650152 |
| 25 | BTK | 1.62529489 |
| 26 | FLT3 | 1.61531652 |
| 27 | MAP3K11 | 1.59712334 |
| 28 | CSK | 1.55847864 |
| 29 | SCYL2 | 1.55668722 |
| 30 | TAOK3 | 1.46783846 |
| 31 | MAP2K3 | 1.45301513 |
| 32 | BMPR2 | 1.42841947 |
| 33 | ITK | 1.42746873 |
| 34 | IKBKB | 1.40312369 |
| 35 | MAP3K14 | 1.40239097 |
| 36 | MATK | 1.37514083 |
| 37 | LRRK2 | 1.20191968 |
| 38 | TEC | 1.18610207 |
| 39 | CAMKK2 | 1.13171480 |
| 40 | MAP3K1 | 1.08626372 |
| 41 | TBK1 | 1.07397367 |
| 42 | FGR | 1.06761044 |
| 43 | JAK3 | 1.04775967 |
| 44 | DMPK | 1.04610228 |
| 45 | MAP3K3 | 1.03319269 |
| 46 | TAOK2 | 1.03297600 |
| 47 | TAOK1 | 0.99394885 |
| 48 | ILK | 0.96864224 |
| 49 | STK16 | 0.96843938 |
| 50 | IRAK1 | 0.93002359 |
| 51 | IRAK3 | 0.92692091 |
| 52 | BMX | 0.92196307 |
| 53 | PTK6 | 0.91766409 |
| 54 | MAP4K2 | 0.90767377 |
| 55 | MARK3 | 0.90317963 |
| 56 | RAF1 | 0.87439282 |
| 57 | MAP2K6 | 0.86523712 |
| 58 | KDR | 0.86029222 |
| 59 | WEE1 | 0.85640238 |
| 60 | MAP3K13 | 0.83947420 |
| 61 | PIK3CA | 0.83447702 |
| 62 | MARK2 | 0.79511789 |
| 63 | PTK2B | 0.77941016 |
| 64 | IRAK4 | 0.76569845 |
| 65 | ACVR1B | 0.75522999 |
| 66 | PIM2 | 0.75517503 |
| 67 | MAPKAPK5 | 0.73557955 |
| 68 | PASK | 0.73141946 |
| 69 | JAK1 | 0.73109315 |
| 70 | PDK1 | 0.73094372 |
| 71 | SIK3 | 0.73079863 |
| 72 | TYK2 | 0.71648009 |
| 73 | IRAK2 | 0.69688535 |
| 74 | CLK1 | 0.69125016 |
| 75 | PIM1 | 0.69031456 |
| 76 | DAPK2 | 0.68447759 |
| 77 | MAP3K5 | 0.68187558 |
| 78 | SYK | 0.67767855 |
| 79 | CDK8 | 0.67554875 |
| 80 | PRKCQ | 0.66956136 |
| 81 | MAPK4 | 0.66598151 |
| 82 | NUAK1 | 0.66525284 |
| 83 | MAPK12 | 0.65651344 |
| 84 | CCNB1 | 0.62702393 |
| 85 | CDK19 | 0.61366719 |
| 86 | PDGFRB | 0.59279220 |
| 87 | TXK | 0.58686554 |
| 88 | MAP3K6 | 0.58561132 |
| 89 | PDPK1 | 0.58212404 |
| 90 | RPS6KA6 | 0.58056301 |
| 91 | FES | 0.57103069 |
| 92 | MAP2K1 | 0.57010916 |
| 93 | PRKD2 | 0.55815815 |
| 94 | CAMKK1 | 0.54856276 |
| 95 | CAMK1 | 0.53948647 |
| 96 | PAK4 | 0.53315618 |
| 97 | CAMK1D | 0.53202040 |
| 98 | LYN | 0.52855031 |
| 99 | RPS6KL1 | 0.51046925 |
| 100 | RPS6KC1 | 0.51046925 |
| 101 | RET | 0.50970018 |
| 102 | RPS6KA4 | 0.50714739 |
| 103 | DAPK3 | 0.49432634 |
| 104 | EPHB1 | 0.49087963 |
| 105 | FYN | 0.47633842 |
| 106 | PAK1 | 0.45705952 |
| 107 | NEK9 | 0.45031590 |
| 108 | MAP3K8 | 0.44941075 |
| 109 | BRSK2 | 0.44062431 |
| 110 | PDGFRA | 0.42660880 |
| 111 | MAPK7 | 0.42483199 |
| 112 | DYRK1B | 0.42059308 |
| 113 | VRK2 | 0.41653512 |
| 114 | LCK | 0.41251800 |
| 115 | CDK4 | 0.40747151 |
| 116 | MAPKAPK2 | 0.40194663 |
| 117 | GRK6 | 0.39761013 |
| 118 | GRK5 | 0.39545847 |
| 119 | RPS6KA2 | 0.39414846 |
| 120 | VRK1 | 0.38995254 |
| 121 | YES1 | 0.38083319 |
| 122 | TSSK6 | 0.37930005 |
| 123 | PRKCD | 0.37744915 |
| 124 | CSF1R | 0.37491958 |
| 125 | TRPM7 | 0.37128345 |
| 126 | GRK7 | 0.36417933 |
| 127 | STK10 | 0.35863436 |
| 128 | MAPK3 | 0.34803346 |
| 129 | RIPK1 | 0.34208504 |
| 130 | ABL1 | 0.33941225 |
| 131 | PRKACB | 0.33318361 |
| 132 | MAPK11 | 0.32770831 |
| 133 | PRKD1 | 0.31283288 |
| 134 | ATR | 0.30644935 |
| 135 | JAK2 | 0.30557333 |
| 136 | IKBKE | 0.29938801 |
| 137 | MAP2K4 | 0.29007913 |
| 138 | HIPK2 | 0.28438252 |
| 139 | PRKG2 | 0.28285641 |
| 140 | CDK6 | 0.28149853 |
| 141 | MAP3K7 | 0.27232415 |
| 142 | SMG1 | 0.26055944 |
| 143 | HCK | 0.25177778 |
| 144 | BLK | 0.24326407 |
| 145 | CDC7 | 0.23389343 |
| 146 | DAPK1 | 0.23296223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 6.63945745 |
| 2 | Protein digestion and absorption_Homo sapiens_hsa04974 | 4.87470626 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.30541550 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.06200859 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.83320096 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.80144247 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.76850164 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.76645956 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.68188920 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58250786 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46273654 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.35276806 |
| 13 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.26940349 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.24699323 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.06472905 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.02131935 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.01673633 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99810504 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99434423 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.94106934 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.89655542 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.80229902 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71698045 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70640325 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.69952796 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68235574 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.56018602 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.43027598 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41790163 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41628236 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39228271 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.28490441 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26703768 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24646606 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22539790 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.13834995 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.12496550 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10117230 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09057699 |
| 40 | * Platelet activation_Homo sapiens_hsa04611 | 1.07638059 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07180903 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04202479 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 1.04191960 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01847209 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94526328 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93238379 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91228437 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90662828 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88979401 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88788984 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88504276 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.82766242 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81284649 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76626781 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76610460 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76358560 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75677387 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74947694 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74856839 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.73245918 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72414078 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71973281 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71586961 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70701526 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70353623 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.70262463 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69751616 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69634478 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68347962 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68299969 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68096650 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67205323 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66378141 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65472755 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64240014 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63486305 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62973526 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.61879365 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61342680 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59822402 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.57104188 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57068286 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.56856366 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.55736573 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55198431 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54617540 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53330985 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53148739 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53068338 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52762320 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.51655501 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51365763 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50264286 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.49671422 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.49300357 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48988754 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46797455 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45972148 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45916349 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45151136 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44757897 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.43377480 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43374933 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42197986 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42152301 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42142811 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41989544 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41565414 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41536012 |
| 110 | RNA polymerase_Homo sapiens_hsa03020 | 0.41479534 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40950921 |
| 112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.40321604 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40046370 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39887486 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39671338 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39611121 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38408159 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37796926 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37697873 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37552282 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35390875 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.34641332 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34162083 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.34099000 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33707910 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33387695 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32806890 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32758683 |
| 129 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32629300 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32092977 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.31053303 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29546239 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.29291756 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28683951 |
| 135 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28185975 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.27955322 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.27063168 |
| 138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26983221 |
| 139 | Spliceosome_Homo sapiens_hsa03040 | 0.26820276 |
| 140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25986560 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.22529956 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22387589 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21333384 |
| 144 | Olfactory transduction_Homo sapiens_hsa04740 | 0.21320868 |
| 145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20437415 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19631904 |
| 147 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19340966 |

